Moderna
MRNA
#203
Rank
NZ$201.53 B
Marketcap
NZ$498.08
Share price
9.93%
Change (1 day)
1,031.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

ESG Reports

Thumbnail Moderna
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Moderna
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report